COSCIENS Biopharma Inc. Liability Asset Of Defined Benefit Plans
COSCIENS Biopharma Inc. (CSCIF) had Liability Asset Of Defined Benefit Plans of $22.24 million as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes
ifrs-full:LiabilityAssetOfDefinedBenefitPlans · last filed 2026-03-25
- 2025-12-31: Liability Asset Of Defined Benefit Plans $22.24M.
- 2025-09-30: Liability Asset Of Defined Benefit Plans $23.50M.
- 2025-06-30: Liability Asset Of Defined Benefit Plans $23.43M.
- 2025-03-31: Liability Asset Of Defined Benefit Plans $22.07M.
| Period end | Liability Asset Of Defined Benefit Plans | Liability Asset Of Defined Benefit Plans as first filed |
|---|---|---|
| 2025-12-31 | $22.24M 20-F · filed 2026-03-25 | |
| 2025-09-30 | $23.50M 6-K · filed 2025-11-12 | |
| 2025-06-30 | $23.43M 6-K · filed 2025-08-14 | |
| 2025-03-31 | $22.07M 6-K · filed 2025-05-13 | |
| 2024-12-31 | $22.40M 20-F · filed 2026-03-25 | |
| 2024-09-30 | $23.84M 6-K · filed 2024-11-12 | |
| 2024-06-30 | $21.88M 6-K · filed 2024-08-13 | |
| 2024-03-31 | $22.91M 6-K · filed 2024-05-16 | |
| 2023-12-31 | $22.14M 6-K · filed 2025-11-12 | $23.72M 20-F · filed 2024-03-27 |
| 2023-09-30 | $20.34M 6-K · filed 2023-11-09 | |
| 2023-06-30 | $22.25M 6-K · filed 2023-08-09 | |
| 2023-03-31 | $22.27M 6-K · filed 2023-05-09 | |
| 2022-12-31 | $21.75M 20-F/A · filed 2024-07-17 | |
| 2022-09-30 | $17.60M 6-K · filed 2022-11-03 | |
| 2022-06-30 | $17.35M 6-K/A · filed 2022-08-04 | |
| 2022-03-31 | $25.60M 6-K · filed 2022-05-11 | |
| 2021-12-31 | $29.41M 20-F/A · filed 2024-07-17 | |
| 2020-12-31 | $15.44M 20-F/A · filed 2024-02-15 | |
| 2019-09-30 | $14.48M 6-K · filed 2019-11-07 | |
| 2019-06-30 | $14.56M 6-K · filed 2019-08-13 | |
| 2018-12-31 | $13.21M 6-K · filed 2019-11-07 | |
| 2017-12-31 | $14.23M 6-K · filed 2019-11-07 |